Wegovy can cause some side effects. The most common side effects of semaglutide are nausea, vomiting, and diarrhoea. Other ...

Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related care to be presented at ECO 2025 - covering burden, and the value of treatment and prevention ...

The banning of pharmaceutical advertisements is not an assault on free speech. Big Pharma cannot be trusted with the health ...

We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...

GLP-1 receptor agonists remain blockbuster drugs for weight management for people with overweight or obesity. Increasingly, ...

Ozempic is already approved to treat T2D ... and atherosclerotic cardiovascular disease and/or chronic kidney disease. The data was presented at ACC by Darren McGuire at UT Southwestern, who ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

For some time now, protein has been the golden child of the nutrition world,” says New York Times best-selling author Joy ...

Now, a modified mask could also protect a wearer by detecting health conditions, including chronic kidney disease. Researchers reporting in ACS Sensors incorporated a specialized breath sensor ...

Opinions expressed are those of the author. The burden of chronic kidney disease (CKD) is staggering: over 35 million people in the U.S. are affected, and in Europe, that number climbs beyond 55 ...

The global burden of chronic kidney disease (CKD) is rising, with more than 800 million people affected worldwide. Vascular diseases in patients with CKD are unique and grouped as uremic vascular ...